Surgical Tourniquets and Cerebral Emboli

Sponsor
University Hospitals Coventry and Warwickshire NHS Trust (Other)
Overall Status
Completed
CT.gov ID
NCT02240732
Collaborator
(none)
12
1
7
1.7

Study Details

Study Description

Brief Summary

BACKGROUND In 2012 76,497 primary total knee (TKR) replacements were performed in England, Wales and Northern Ireland . Traditionally TKR surgery is undertaken with the aid of a surgical tourniquet. A surgical tourniquet is an occlusive device applied around a patient's leg. The tourniquet squeezes the leg (including blood vessels within the leg) and can therefore reduce the amount of bleeding that occurs while it is inflated. An intraoperative tourniquet can therefore help to improve the surgical field of view. Although the majority of surgeons prefer to undertake TKR surgery using a tourniquet a small but increasing number are now not pursuing these devices.

There is robust evidence that the risk of deep vein thrombosis is increased if a tourniquet is used for TKR surgery. In addition embolic material in the venous system have been observed following TKR surgery and have been noted to be present in the right atrium with transoesophageal (TOE) echo intra-operatively. , Significant and potentially life threatening emboli have been documented to enter the cerebral circulation via pulmonary arterio-venous shunts and patent foramen ovale (PFO) (27% of patients at autopsy) , . The clinical manifestations of cerebral emboli post tourniquet deflation in TKR are not fully understood. Fat embolism syndrome and post-operative confusion in TKR patients may be the result of emboli formed during a TKR. ,

AIM

  • Is there evidence of emboli entering the cerebral circulation following tourniquet deflation in TKR surgery?

  • Is there evidence of MRI detectable brain lesions and or any clinical change in cognition compared in patients undergoing TKR surgery with a tourniquet compared to those that do not have a tourniquet?

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    12 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Surgical Tourniquets and Cerebral Emboli Pilot Study
    Study Start Date :
    Sep 1, 2014
    Actual Primary Completion Date :
    Apr 1, 2015
    Actual Study Completion Date :
    Apr 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Total knee replacement patients

    Patients who are due to have a total knee replacement will be studied to look for the presence of Emboli. Observational with imaging.

    Outcome Measures

    Primary Outcome Measures

    1. Number of Emboli on Transcranial Doppler [Intra-operative]

      2 independent technicians will verify the number of emboli detected. Non-invasive

    2. MRI brain scan - presence of Emboli [Post-operatively, prior to discharge]

      Reviewed by Professor of radiology - presence, number and volume of diffusion weighted lesions

    Secondary Outcome Measures

    1. Mini-mental state examination [Pre-operative vs Post-operative]

      Set of 30 questions which test cognitive function

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • i.Aged >18

    • ii.Undergoing elective TKR

    • iii.Able to give written informed consent

    • iv.No contraindications to MR imaging

    Exclusion Criteria:
      1. Ages <16
      1. Not able to give written informed consent
      1. Contraindications to MR imaging

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital Warwickshire and Coventry Coventry United Kingdom CV2 2DX

    Sponsors and Collaborators

    • University Hospitals Coventry and Warwickshire NHS Trust

    Investigators

    • Principal Investigator: Victoria Gibbs, BA, MBBS, UHCW

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Victoria Gibbs, Doctor, University Hospitals Coventry and Warwickshire NHS Trust
    ClinicalTrials.gov Identifier:
    NCT02240732
    Other Study ID Numbers:
    • STCE2.0
    First Posted:
    Sep 16, 2014
    Last Update Posted:
    Jun 30, 2015
    Last Verified:
    Jun 1, 2015
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 30, 2015